↓ Skip to main content

Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway

Overview of attention for article published in Clinical and Molecular Allergy, February 2011
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway
Published in
Clinical and Molecular Allergy, February 2011
DOI 10.1186/1476-7961-9-5
Pubmed ID
Authors

Fredrik Thorn, Halvor Celius, Tone Ødegård, Randeep Mandla, Erik Hexeberg

Abstract

In 2006, the Norwegian Medicines Agency mandated a switch from desloratadine, ebastine, or fexofenadine to cetirizine or loratadine in patients with allergic rhinitis (AR) or chronic urticaria (CU). In an online survey, patients whose medication was switched assessed the impact on efficacy, fatigue, and work productivity/attendance.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Turkey 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Other 3 20%
Researcher 3 20%
Professor > Associate Professor 3 20%
Student > Doctoral Student 2 13%
Student > Master 1 7%
Other 3 20%
Readers by discipline Count As %
Medicine and Dentistry 11 73%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Social Sciences 1 7%
Psychology 1 7%
Unknown 1 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2012.
All research outputs
#13,360,458
of 22,663,969 outputs
Outputs from Clinical and Molecular Allergy
#144
of 211 outputs
Outputs of similar age
#80,697
of 108,254 outputs
Outputs of similar age from Clinical and Molecular Allergy
#3
of 3 outputs
Altmetric has tracked 22,663,969 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 211 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.